Preliminary activity of devimistat (CPI 613) in patients with relapsed or refractory Burkitt lymphoma/leukemia Meeting Abstract


Authors: Nikolaenko, L.; Pardee, T. S.; Steiner, R.; Abramson, J. S.; Horwitz, S.; Matasar, M.; Owens, C.; Rodriguez-Rivera, I.; Straus, D.; Luther, S.; Noy, A.
Abstract Title: Preliminary activity of devimistat (CPI 613) in patients with relapsed or refractory Burkitt lymphoma/leukemia
Meeting Title: 16th International Conference on Malignant Lymphoma - Virtual Edition
Journal Title: Hematological Oncology
Volume: 39
Issue: Suppl. 2
Meeting Dates: 2021 Jun 18-22
Meeting Location: Virtual
ISSN: 0278-0232
Publisher: Wiley Blackwell  
Date Published: 2021-06-01
Start Page: 456
End Page: 457
Language: English
ACCESSION: 150947685
DOI: 10.1002/hon.84_2881
PROVIDER: EBSCOhost
PROVIDER: cinahl
PUBMED: 34105791
DOI/URL:
Notes: Meeting Abstract: 371 -- Accession Number: 150947685 -- Entry Date: In Process -- Revision Date: 20210618 -- Publication Type: Article -- Supplement Title: Jun2021 Supplement S2 -- Journal Subset: Biomedical; Europe; Peer Reviewed; UK & Ireland -- NLM UID: 8307268. -- Source: Cinahl
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ariela Noy
    351 Noy
  2. Steven M Horwitz
    645 Horwitz
  3. Matthew J Matasar
    289 Matasar
  4. David J Straus
    356 Straus
  5. Colette Ngozi Owens
    66 Owens